Trademark: 79310056
Status Date
Tuesday, July 12, 2022
Registration Number
6784079
Registration Date
Tuesday, July 12, 2022
Filing Date
Friday, February 26, 2021
Published for Opposition
Tuesday, April 26, 2022
5 Pharmaceutical preparations and substances for use in gene therapy, namely, for treatment of sickle cell disease
Dec 23, 2023
Change Of Name/Address Rec'd From Ib
Nov 14, 2022
Final Decision Transaction Processed By Ib
Oct 19, 2022
Final Disposition Notice Sent To Ib
Oct 19, 2022
Final Disposition Processed
Oct 12, 2022
Final Disposition Notice Created, To Be Sent To Ib
Aug 26, 2022
Change Of Name/Address Rec'd From Ib
Jul 12, 2022
Notice Of Registration Confirmation Emailed
Jul 12, 2022
Registered-Principal Register
May 3, 2022
Notification Processed By Ib
Apr 26, 2022
Official Gazette Publication Confirmation E-Mailed
Apr 26, 2022
Published For Opposition
Apr 13, 2022
Notification Of Possible Opposition Sent To Ib
Apr 13, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Apr 6, 2022
Notification Of Notice Of Publication E-Mailed
Mar 22, 2022
Approved For Pub - Principal Register
Mar 11, 2022
Teas/Email Correspondence Entered
Mar 10, 2022
Correspondence Received In Law Office
Mar 10, 2022
Teas Response To Office Action Received
Oct 25, 2021
Refusal Processed By Ib
Oct 9, 2021
New Representative At Ib Received
Sep 14, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Sep 14, 2021
Refusal Processed By Mpu
Sep 12, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Sep 11, 2021
Non-Final Action Written
Sep 9, 2021
Assigned To Examiner
Aug 13, 2021
Change Of Owner Received From Ib
May 14, 2021
Application Filing Receipt Mailed
May 10, 2021
New Application Office Supplied Data Entered
May 8, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
